Literature DB >> 15732112

Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1.

Andreas Goebel, Michael Stock, Rob Deacon, Guenter Sprotte, Angela Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15732112     DOI: 10.1002/ana.20400

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  13 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.

Authors:  Marinos C Dalakas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 3.  Immunoglobulin responsive chronic pain.

Authors:  Andreas Goebel
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

4.  7th International Immunoglobulin Conference: Neurology.

Authors:  E Nobile-Orazio; R A Lewis
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 5.  IVIg in other autoimmune neurological disorders: current status and future prospects.

Authors:  Marinos Dalakas
Journal:  J Neurol       Date:  2008-07       Impact factor: 4.849

6.  Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Xiaoyou Shi; Eva Czirr; Trisha Stan; Peyman Sahbaie; Tony Wyss-Coray; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2014-09-10       Impact factor: 6.961

7.  The prevalence of autoantibodies in complex regional pain syndrome type I.

Authors:  Maaike Dirckx; Marco W J Schreurs; Marissa de Mos; Dirk L Stronks; Frank J P M Huygen
Journal:  Mediators Inflamm       Date:  2015-02-08       Impact factor: 4.711

8.  Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial.

Authors:  Andreas Goebel; Nicholas Shenker; Nick Padfield; Karim Shoukrey; Candida McCabe; Mick Serpell; Mark Sanders; Caroline Murphy; Amaka Ejibe; Holly Milligan; Joanna Kelly; Gareth Ambler
Journal:  Trials       Date:  2014-10-24       Impact factor: 2.279

9.  Passive transfer autoimmunity in a mouse model of complex regional pain syndrome.

Authors:  Tian-Zhi Guo; Xiaoyou Shi; Wen-Wu Li; Tzuping Wei; John David Clark; Wade S Kingery
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

10.  Amyloid β Enhances Typical Rodent Behavior While It Impairs Contextual Memory Consolidation.

Authors:  Karla Salgado-Puga; Roberto A Prado-Alcalá; Fernando Peña-Ortega
Journal:  Behav Neurol       Date:  2015-07-01       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.